Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) FCF Margin (2016 - 2025)

Standard Biotools (LAB) has disclosed FCF Margin for 16 consecutive years, with 24.32% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 9471.0% to 24.32% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 71.0% through Dec 2025, up 6113.0% year-over-year, with the annual reading at 88.12% for FY2025, 7869.0% up from the prior year.
  • FCF Margin for Q4 2025 was 24.32% at Standard Biotools, up from 152.65% in the prior quarter.
  • The five-year high for FCF Margin was 24.32% in Q4 2025, with the low at 174.92% in Q3 2021.
  • Average FCF Margin over 5 years is 91.6%, with a median of 73.78% recorded in 2022.
  • The sharpest move saw FCF Margin crashed -16253bps in 2021, then skyrocketed 12795bps in 2023.
  • Over 5 years, FCF Margin stood at 174.92% in 2021, then skyrocketed by 58bps to 73.78% in 2022, then skyrocketed by 46bps to 40.12% in 2023, then tumbled by -75bps to 70.39% in 2024, then skyrocketed by 135bps to 24.32% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 24.32%, 152.65%, and 72.59% for Q4 2025, Q3 2025, and Q2 2025 respectively.